RA
TMO icon

Riversedge Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Riversedge Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$365K Buy
+540
New +$321K 0.04% 201

Other funds holding TMO

SP
Sarasin & Partners London, United Kingdom $8.93B AUM 11.81% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return
CIPU
Caledonia Investments plc (UK) London England, United Kingdom $890M AUM 1.23% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
QPBE
Quintet Private Bank (Europe) Luxembourg $2.28B AUM 23.89% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

Riversedge Advisors's TMO Position: Q3 2026 in Review

Riversedge Advisors opened a new position in Thermo Fisher Scientific (TMO) in Q3 2026: 540 shares worth $365K. The stake represents 0.04% of the portfolio and ranks #201 among its holdings.

302 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Riversedge Advisors held 540 shares of Thermo Fisher Scientific worth $365K as of Q3 2026.
  • Thermo Fisher Scientific was a new Riversedge Advisors position in Q3 2026.
  • Thermo Fisher Scientific made up 0.04% of Riversedge Advisors's portfolio in Q3 2026, its #201 holding.
  • 302 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Riversedge Advisors's 13F filing for Q3 2026, filed 9 Oct 2026.